Promacta 25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9BEG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,968
Award facts
- Contract value 100% obligated
- $13,967.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Promacta 25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $13,967.88. This is a non-set-aside competitive award with performance requirements through January 2, 2026, and fulfillment at the vendor's Conshohocken, Pennsylvania location. This delivery order is a child contract issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 through December 2026 that enables the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's portfolio includes brand-name and generic medications across multiple therapeutic domains, positioning it to meet the Defense Logistics Agency's medical supply requirements through competitive procurement. The DLA is currently planning to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, reflecting the strategic importance of reliable pharmaceutical distribution to military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9BEG?
SPE2DR26F9BEG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F9BEG worth?
The government has obligated $13,968 on SPE2DR26F9BEG.
Is contract SPE2DR26F9BEG an order under another contract?
Yes. SPE2DR26F9BEG is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BEG competed?
The extent of competition for SPE2DR26F9BEG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award